P09.28 MGMT promoter methylation status in glioblastoma (GBM) patients: a quantitative pyrosequencing approach and its prognostic role

Background: MGMT gene promoter methylation status is acknowledged as a prognostic factor and predictive marker for temozolomide (TMZ) treatment. Although MGMT status determined by pyrosequencing was showed to correlate with progression free survival (PFS) and overall survival (OS), it is still uncle...

पूर्ण विवरण

में बचाया:
ग्रंथसूची विवरण
में प्रकाशित:Neuro Oncol
मुख्य लेखकों: Lombardi, G., Bellu, L., Bertorelle, R., Pambuku, A., Gardiman, M., Fiduccia, P., Della Puppa, A., Berti, F., D’Avella, D., Zagonel, V.
स्वरूप: Artigo
भाषा:Inglês
प्रकाशित: Oxford University Press 2017
विषय:
POSTER PRESENTATIONS
ऑनलाइन पहुंच:https://ncbi.nlm.nih.gov/pmc/articles/PMC5464051/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nox036.284
टैग : टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!

समान संसाधन